Conference abstracts of a new oncology drug do not always lead to full publication: Proceed with caution

Journal of Clinical Epidemiology

Volumn 62, Issue 7, 2009, Pages 752-758

  Kho, Michelle E ^a   Brouwers, Melissa C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Program in Evidence based Care   (Canada)

Author keywords

Bias; Epidemiology; Medical; Medical oncology; Publication bias; Publishing; Rituximab; Societies

Indexed keywords

RITUXIMAB;

ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER RESEARCH; CLINICAL TRIAL; DECISION MAKING; DRUG RESEARCH; FOLLOW UP; HUMAN; MEDICAL LITERATURE; MEDICAL SOCIETY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PUBLICATION;

ABSTRACTING AND INDEXING AS TOPIC; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIBLIOMETRICS; CONGRESSES AS TOPIC; DIFFUSION OF INNOVATION; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PUBLICATION BIAS; PUBLISHING; TIME FACTORS;

EID: 67349085753     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2008.09.006     Document Type: Article

References (22)

1. De Bellefeuille C., Morrison C.A., and Tannock I.F. The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication. Ann Oncol 3 3 (1992) 187-191
2. Cook D.J., Guyatt G.H., Ryan G., Clifton J., Buckingham L., Willan A., et al. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA (1993) 2749-2753 269
3. Scherer R.W., Langenberg P., and von Elm E. Full publication of results initially presented in abstracts. Cochrane Database Syst Rev 2 (2007) MR000005
4. Krzyzanowska M.K., Pintilie M., and Tannock I.F. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 290 (2003) 495-501
5. Camacho L.H., Bacik J., Cheung A., and Spriggs D.R. Presentation and subsequent publication rates of phase I oncology clinical trials. Cancer 104 (2005) 1497-1504
6. Papagikos M.A., Rossi P.J., and Lee W.R. Publication rate of abstracts from the annual ASTRO meeting: comparison with other organizations. J Am Coll Radiol 2 1 (2005) 72-75
7. Streiner D.L., and Norman G.R. Health measurement scales: a practical guide to their development and use. 3rd ed. (2003), Oxford University Press, New York
8. Bhandari M., Devereaux P.J., Guyatt G.H., Cook D.J., Swiontkowski M.F., Sprague S., et al. An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am 84-A (2002) 615-621
9. Burns K.E., Adhikari N.K., Kho M., Meade M.O., Patel R.V., Sinuff T., et al. Abstract reporting in randomized clinical trials of acute lung injury: an audit and assessment of a quality of reporting score. Crit Care Med 33 (2005) 1937-1945
10. Kho ME, Eva KW, Cook DJ, Brouwers MC. The completeness of reporting (CORE) index identifies important deficiencies in observational study conference abstracts. J Clin Epidemiol, in press.
11. Ridker P.M., and Torres J. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA 295 (2006) 2270-2274
12. Michaelis L.C., and Ratain M.J. Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties. Clin Cancer Res 13 (2007) 2400-2405
13. Norman G.R., and Streiner D.L. Biostatistics: the bare essentials. 2nd ed. (2000), BC Decker Inc., Hamilton
14. Kleinbaum D.G., and Klein M. Logistic regression: a self-learning text. 2nd ed. (2002), Springer, New York, NY
15. Kleinbaum D.G., and Klein M. Survival analysis: a self-learning text. 2nd ed. (2005), Springer, New York, NY
16. Voog E., Morschhauser F., and Solal-Celigny P. Neutropenia in patients treated with rituximab. N Engl J Med 348 26 (2003) 2691-2694 [discussion 4]
17. Simes R.J. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 4 10 (1986) 1529-1541
18. Toma M., McAlister F.A., Bialy L., Adams D., Vandermeer B., and Armstrong P.W. Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA 295 11 (2006) 1281-1287
19. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 1 (1977) 159-174
20. Krzyzanowska M.K., Pintilie M., Brezden-Masley C., Dent R., and Tannock I.F. Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting. J Clin Oncol 22 10 (2004) 1993-1999
21. Hopewell S., Clarke M., Moher D., Wager E., Middleton P., Altman D.G., et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 5 1 (2008) e20
22. Cancer care Ontario drug formulary-rituximab. 2005 Available at www.cancercare.on.ca/pdfchemo/rituximab-NHLlo.pdf. Accessed November 21, 2007.